Less Intensive Diabetes Treatment May Benefit Patients at Risk for Hypoglycemia
Intensive glucose-lowering therapy is prevalent among U.S. adults with diabetes and results in hospitalizations and emergency department visits for hypoglycemia.
Hypoglycemia
Diabetes Self-Management Education May Reduce Hypoglycemia Risk
Diabetes self-management education and support can cut hypoglycemia risk.
FDA Approves Glucagon Nasal Powder to Treat Severe Hypoglycemia
The Food and Drug Administration (FDA) has approved Baqsimi (glucagon; Eli Lilly) nasal powder for the treatment of severe hypoglycemia in patients with diabetes aged 4 years and older.
Avexitide Granted Breakthrough Therapy Designation for Post-Bariatric Hypoglycemia
FDA has granted Breakthrough Therapy designation to avexitide (Eiger Biopharmaceuticals) for the treatment of post-bariatric hypoglycemia (PBH).
Additional Positive Phase 3 Data Announced for Ready-to-Use Glucagon Autoinjector
If approved, it would be the first room temperature stable liquid glucagon in an autoinjector formulation.
Dasiglucagon Is a Promising Treatment Option for Severe Hypoglycemia
Dasiglucagon was found to be an effective and safe treatment option for severe hypoglycemia in type 1 diabetes.
Hypoglycemia at End of Hospital Stay Linked to Readmission, Mortality in Diabetes
For patients with diabetes who are hospitalized, hypoglycemia or near-normal glucose values during the last 24 hours of hospitalization can lead to higher rates of 30-day readmission and mortality.
Approved Glucose Monitor Does Not Meet Regulatory Standards, May Overestimate Hypoglycemic Values
The MyGlucoHealth blood glucose meter did not meet regulatory standards and may overestimate values in the hypoglycemic range.
Wearable Device for Heart Rate Variability Can Detect Early Hypoglycemia
A wearable device that measures real-time heart rate variability can detect early signs of hypoglycemia in patients with type 1 diabetes.
Hypoglycemia Often Unrecognized by Older Adults With T1D
Blood sugar levels of older adults with type 1 diabetes are in the hypoglycemic range for more than an hour a day, and blood sugar levels of those with impaired hypoglycemia awareness may be in hypoglycemic range even longer.
Next post in ENDO 2019
